1. ANGELA B. LASHER, Ph.D
13904 Resin Ct.
Bowie, MD 20720
Home phone number: (301) 262-8849
Work phone number: (240) 402-1763
United States citizen
angela.lasher@fda.hhs.gov
______________________________________________________________________________
Education
8/94-4/99 Doctorate of Philosophy in Economics, University of Kentucky, 1999
Lexington, KY 40506
Fields: Health Care, Industrial Organization, and Public Choice
Teaching Assistantship, courses taught: Economic Principles, Econometrics
Dissertation: “Essays on the Development and FDA Approval of Pharmaceutical Drugs”
Semester hours: 51
GPA: 3.176
8/91-6/94 Bachelor of Science in Economics, University of Evansville, 1994
Evansville, IN 47722
Received the Prof. L. W. Anderson Civitan Award for Outstanding Scholarship in
Business and Economics, 1994
Semester hours: 133
GPA: 3.8339
Employment Experience
1/01-current Senior Economist, Acting Supervisory Economist
Series 0110, GS-14
U.S. Food and Drug Administration
Office of the Commissioner, Office of Planning
5100 Paint Branch Parkway, HFS-020
College Park, MD 20740
Duties and Accomplishments:
Provide supervision and guidance to 3 staff economists
• Supervise 3 FTEs with advanced degrees (Ph.Ds) and varying range of experience (1
year experience to over 10 years of experience)
• Evaluate work product and provide expert review
• Mentor FTEs to promote career satisfaction and advancement
Analyze, both quantitatively and qualitatively, the public health benefits and costs
of FDA policies, statutes, and regulations
• Develop high-quality economic impact analyses for food safety documents
• Provide expert review of FDA and other food safety related materials for internal use
and for public dissemination
• Evaluate and assess data on foodborne illness

2. • Coordinate and manage complex science policy analyses with outside contractors
• Brief and advise HHS and FDA management, both orally and in writing, on the
economic effects of public health science policy decisions
• Work with USDA and CDC on interagency projects involving human health and
food safety
Provide Expertise for Major Science Policy Areas of Food Safety
• Preventive Controls and Risk-Based Analyses for food processing facilities
• Risk Ranking Most Significant Foodborne Contaminants
• Burden of foodborne illnesses by pathogen type
• Burden of variant Creutzfeldt-Jakob disease
• Burden of BSE – effects of BSE and the banning of the use of bovine specified risk
materials in human foods and cosmetics
• Effects of food handling practices on the incidence of foodborne illness
• Food GMPs-Industry Manufacturing Processes
• Effects of regulation on Small Businesses in the Food Industry
• Costs and benefits of a Prior Notice of Imported Food regulation
11/08-12/08 *Detail*
CFSAN Economics Team Leader (Supervisory Economist)
Series 0110, GS-14
U.S. Food and Drug Administration
Center for Food Safety and Applied Nutrition (CFSAN)
Office of Regulations, Policy, and Social Sciences
5100 Paint Branch Parkway, HFS-020
College Park, MD 20740
Duties and Accomplishments:
• Managed 7 FDA-CFSAN regulatory economists
• Reviewed and revised science policy analyses written by staff economists
• Coordinated science policy program and project efforts within FDA
• Made science policy recommendations to FDA-CFSAN management
• Briefed, both orally and in writing, FDA-CFSAN management on science policy
issues
10/05-12/05 *Detail*
CFSAN Economics Team Leader (Supervisory Economist)
Series 0110, GS-13
U.S. Food and Drug Administration
Center for Food Safety and Applied Nutrition (CFSAN)
Office of Regulations, Policy, and Social Sciences
5100 Paint Branch Parkway, HFS-020
College Park, MD 20740
Duties and Accomplishments:

3. • Managed 6 FDA-CFSAN regulatory economists
• Reviewed and revised science policy analyses written by staff economists
• Coordinated science policy program and project efforts within FDA
• Made science policy recommendations to FDA-CFSAN management
• Briefed, both orally and in writing, FDA-CFSAN management on science policy
issues
11/04-1/05 *Detail*
Economist
Series 0110, GS-13
HHS- Office of the Assistant Secretary for Planning and Evaluation (ASPE)
Office of Science and Data Policy
Duties and Accomplishments:
• Analyzed and evaluated science policy, legislative, and regulatory issues
• Made science policy recommendations to the Assistant Secretary regarding
concurrence or non-concurrence with FDA rules
• Reviewed science policy, legislative and regulatory reports and analyses for all areas
of FDA-drugs, medical devices, biologics, and foods
• Conducted science policy and program research, both independently and as part of a
team, on food and drug science and public health issues
Special Programs:
8/05-8/06 Center for Food Safety and Applied Nutrition Leaders Developing Leaders Program
• One of only 8 people selected in CFSAN to participate in year-long intensive training
program for Developing Leaders at CFSAN
• Intensive program in addition to regular duties as FDA economist
• Involved in coordination and execution of the FDA effort in the National Capitol
Area Combined Federal Campaign (CFC) for 2005
• Designed, coordinated, and participated in joint CFSAN and Health Canada Listeria
in Cheeses Analytica Training Workshop (April 2006)
Some FDA Awards Received for Science Policy Analysis and Research:
• FDA Group Recognition Award for work on the Preventive Controls for Human
Food Regulation (2015)
• FDA Group Recognition Award for work on the Interagency Food Safety Analytics
Collaboration (2015)
• FDA Group Recognition Award for work on Food Safety Modernization Act
(FSMA) (2014)
• FDA Group Recognition Award for work on the Intentional Adulteration Regulation
Team (FSMA) (2014)

4. • FDA Commissioner Special Citation for work on Food Safety Modernization Act
(FSMA) (2013)
• Director’s Special Citation as member of Reportable Food Registry 1.0 Team (2011)
• Group Recognition Award for Prior Notice Final Rule Development (2009)
• Team Spirit Award for work on Food GMP Survey (2009)
• Team Award for Dietary Supplement and OTC Drug Act Implementation (2008)
• Group Recognition Award for CGMPs for Dietary Supplements (2008)
• Quality Work Award for Dietary Supplement Final Rule (2007)
• Team Award for Fresh-Cut Guidance (2006)
• FDA/CFC Special Service Award, Campaign Manager, Combined Federal Campaign
(2005)
• Team Award for National Infrastructure Protection Plan (2005)
• Team Award for Early Food Safety Evaluation of new Non-Pesticidal Proteins
(2005)
• FDA Commissioner’s Special Citation the Bioterrorism Act Administrative
Detention Rule (2005)
• FDA Commissioner’s Special Citation for Prior Notice Rule (2004)
• Quality Performance Award for Cost Benefit Analysis of BT Prior Notice rule (2003)
• Quality Performance Award for the Food Safety Handling Practices Model (2003)
• Secretary’s Award for Distinguished Service, FDA Bioterrorism Preparedness Team
(2003)
• FDA Plain Language Award, Prior Notice Proposed Rule Group (2003)
• FDA Leveraging/Collaboration Award for launching the Interagency Economic Peer
Review (IEPR) process (2003)
• Quality Performance Award for contract management (2002)
• Quality Performance Award for work with the Interstate Travel Program (2002)
Publications and Presentations:
• Minor, T, Lasher, A., Klontz, K, Brown, B., Nardinelli, C., and Zorn, D. “The Per
Case and Total Annual Costs of Foodborne Illness in the United States”, Journal of
Risk Analysis (forthcoming).
• Lasher, Angela, “A Method to Estimate the Burden of Foodborne Illness”,
Interagency Risk Assessment Consortium (IRAC) Public Conference, November,
2007.
• Ritzert (Lasher), A., Kendall, D., Viator, C., Karns, S., Durocher, B., Modeling the
Effects of Food Handling Practices on the Incidence of Foodborne Illness,
Presentation, Society for Risk Analysis, December 2004.
• Ritzert (Lasher), A. Review of: Medicare Reform: Issues and Answers, Andrew J.
Rettenmaier and Thomas R. Saving (Eds), Public Choice, October 2000, Volume
105, Issue 1-2, pp 197-200.
05/99-1/01 Health Economist
Joint Economic Committee
United States Senate
G-01 Dirksen Senate Office Building

5. Washington, D.C. 20510
Duties and Accomplishments:
• Gathered, assembled, and analyzed facts for various economic reports and documents
to assist the Committee Chairman and Members in performing their statutory
obligation and to assist the public in interpreting economic issues
• Advised, both orally and in writing, the Executive Director and Chief Economist
regarding the development of Committee hearings, including drafting of background
memoranda and questions for witnesses on budgetary, legislative, regulatory, and
science policy issues.
• Monitored legislative, regulatory, and budgetary economic and science policy issues,
including quantitative and qualitative reports on all economic issues relating to
assigned topics
Reports and writings for the Joint Economic Committee include:
• “A Social Security System for the 21st
Century” September 2000
• “The Benefits of Medical Research and the Role of the NIH” May 2000
• Report of the Joint Economic Committee on the 1999 Economic Report of the
President, October 1999
• “Putting a Human Face on Biotechnology: A Report on the Joint Economic
Committee’s Biotechnology Summit” October 1999
• “American Leadership in the Innovation Economy: A Report on the Joint Economic
Committee’s National High-Technology Summit” July 1999
8/98-5/99 Visiting Professor of Economics
Peter T. Paul College of Business and Economics
Duties and Accomplishments:
• Taught Economic Principles and Health Care Economics classes to undergraduates
• Counseled students on Economic questions and class choices
• Contributed to faculty and Business School preparation of student curriculum

6. Washington, D.C. 20510
Duties and Accomplishments:
• Gathered, assembled, and analyzed facts for various economic reports and documents
to assist the Committee Chairman and Members in performing their statutory
obligation and to assist the public in interpreting economic issues
• Advised, both orally and in writing, the Executive Director and Chief Economist
regarding the development of Committee hearings, including drafting of background
memoranda and questions for witnesses on budgetary, legislative, regulatory, and
science policy issues.
• Monitored legislative, regulatory, and budgetary economic and science policy issues,
including quantitative and qualitative reports on all economic issues relating to
assigned topics
Reports and writings for the Joint Economic Committee include:
• “A Social Security System for the 21st
Century” September 2000
• “The Benefits of Medical Research and the Role of the NIH” May 2000
• Report of the Joint Economic Committee on the 1999 Economic Report of the
President, October 1999
• “Putting a Human Face on Biotechnology: A Report on the Joint Economic
Committee’s Biotechnology Summit” October 1999
• “American Leadership in the Innovation Economy: A Report on the Joint Economic
Committee’s National High-Technology Summit” July 1999
8/98-5/99 Visiting Professor of Economics
Peter T. Paul College of Business and Economics
Duties and Accomplishments:
• Taught Economic Principles and Health Care Economics classes to undergraduates
• Counseled students on Economic questions and class choices
• Contributed to faculty and Business School preparation of student curriculum